Veröffentlicht
14.09.2026
Zuschlag erteilt
14.09.2026
Vivus LLC, 65IB, 36F79726D0185, Performance Period: 09/29/2026 - 09/30/2031
Sumitomo Pharma America, Inc. 09/01/2026 - 08/31/2031
Sumitomo Pharma America, Inc. 09/01/2026 - 08/31/2031
Novum Medical Products of NY, LLC 65IIA, 36F79726D0188 Effective 9/1/2026/Expires 8/31/2031
Americare, LLC. 65IIA Base Period of Performance 09/01/2026 - 08/31/2031
Butler Dynamics, LLC (65IIA) 09/01/2026 -08/31/2031
Mesalamine 1200mg Tablet (VA-27-00000768)
Philadelphia VA Medical Center Radiopharmacueticals
Philadelphia VA Medical Center Radiopharmacueticals
Bupropion HCL ER
SNS Pharmaceutical Logistic Replenishment Requirement
Progesterone Capsules
C--WOOLPERT GEOSPATIAL PRODUCTS AND SERVICES CONTRACT v4 (GPSC4)
SR Power Supplies Rack Detailed Design for ALS-U
Emergency Response Wraparound Services
Wheat DNA Library Sequencing
Cable Fiber Install ATC Tower Dobbins ARB
J--Flooring Replacement and Baseboard, Bldg 50, BIA,
© 2026 SIA «Vietne». Alle Rechte vorbehalten.